Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma.

Saved in:
Bibliographic Details
Title: Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma.
Authors: Li Q; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China., Zhu L; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China., Ma Y; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China., Ma J; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China., Zhang M; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China., Lin Z; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China. zhiguang_lin@163.com., Chen B; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China. bbchen@fudan.edu.cn.
Source: Annals of hematology [Ann Hematol] 2026 Feb 25; Vol. 105 (4). Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-026-06749-z